Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Leadership
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Offices
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Search
  • Full Menu

Main Menu

  • Who We Are
  • What We Do
  • Careers
  • Resources
  • Submit A Tip
  • Get Updates
  • Scam Alert
  • English
  • ES

PUBLIC SAFETY ALERT

DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine - DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine

Drug Enforcement Administration

Deanne L. Reuter Special Agent in Charge
Miami
@deamiamidiv
July 27, 2022
Contact: Miami.FD.PIO@dea.gov
Phone Number:
For Immediate Release

Federal Court Orders Clinic to Close, Physician and Clinic Owners to Pay $600,000 for Alleged Unlawful Opioid Distribution

WASHINGTON – A federal court ordered a Tampa-area pain management clinic to close and directed the clinic’s owners and its former physician to collectively pay $600,000 in civil penalties pursuant to agreed resolutions in a case alleging violations of the Controlled Substances Act (CSA), the Justice Department announced today. 

In a complaint filed in February 2021, the United States alleged that Dr. Tobias Bacaner wrote prescriptions for opioids without a legitimate medical purpose and outside the usual course of professional practice while employed at Paragon Community Healthcare, a pain clinic in New Port Richey, Florida. The complaint alleged that Paragon’s owners, Theodore Ferguson II and Timothy Ferguson, managed the clinic’s operations and profited from the unlawful prescribing while ignoring obvious signs of drug abuse and diversion. The complaint further alleged that Dr. Bacaner and the Fergusons used their jointly owned pharmacy, Cobalt Pharmacy, to unlawfully fill prescriptions issued at Paragon without scrutiny.

The order against Dr. Bacaner requires him to pay $500,000 in civil penalties and prohibits him from prescribing, administering, dispensing or distributing controlled substances, among other restrictions. The order against the Fergusons and Paragon requires them to jointly pay $100,000 in civil penalties. The order also requires Paragon to permanently close, and places restrictions on the Fergusons’ ability to own or work at entities that administer, dispense or distribute controlled substances in the future. The defendants also agreed to permanently dissolve Cobalt Pharmacy, which closed shortly before the government filed suit.

“Physicians who prescribe opioids without a legitimate medical purpose and outside of the usual course of professional practice and others who facilitate that conduct will be held accountable,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Justice Department’s Civil Division. “The department will continue to aggressively use all available enforcement remedies to prevent the unlawful diversion of potentially dangerous prescription drugs.”

“Dr. Bacaner and his associates profited from unlawfully prescribing opioids without a legitimate medical purpose,” said U.S. Attorney for the Middle District of Florida Roger B. Handberg. “We will continue to protect the community from those who place a higher value on profit than the safety of the public.”

“Our communities place trust in their medical professionals to help them. The actions of Dr. Bacaner and owners of this clinic violated this trust,” said Drug Enforcement Administration (DEA) Miami Field Division Special Agent in Charge Deanne L. Reuter. “This settlement highlights DEA’s commitment to hold medical providers accountable for violating laws designed to protect the health and safety of our communities. The closure of these businesses and the prohibition to continue to exploit those in need, ensures the wellbeing of patients everywhere.”  

The investigation was conducted by the DEA Tampa District Office.

U.S. District Judge Virginia M. Hernandez Covington entered the consent decree in U.S. District Court for the Middle District of Florida.

The United States was represented by Assistant U.S. Attorney Lindsay S. Griffin and Trial Attorneys Scott Dahlquist and Tom Rosso of the Justice Department’s Consumer Protection Branch.

If you are aware of controlled substance violations in your community, please submit your anonymous tip through the DEA online Tip Line at Submit a Tip | DEA.gov.  Concerns about prescription drug abuse or diversion can be reported to the DEA through this link: RX Abuse Online Reporting (usdoj.gov).

The DEA encourages parents, teachers, care givers, guardians, and children to educate themselves about the dangers of drugs by visiting DEA’s interactive websites at www.JustThinkTwice.com , www.GetSmartAboutDrugs.com , www.CampusDrugPrevention.gov , and www.dea.gov.

Follow DEA Miami via Twitter at @DEAMIAMIDIV

Opioids
  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster